HCPCS Q2035: Influenza Vaccine (Afluria), IM, Age 3+
HCPCS Level II code Q2035 describes the influenza virus vaccine, split virus formulation (Afluria) for intramuscular administration in individuals aged 3 years and older; this represents a single-dose injectable vaccine product used for preventive immunization against seasonal influenza, typically provided in outpatient clinic, physician office, pharmacy, or community vaccination settings as a routine immunization service.
Customize your policy alerts
Sign up for hcpcs Q2035 policy alerts
Get alerted when payer policies referencing Q2035 are released or updated.
Monitor payer policy activity